About AbFero Pharmaceuticals
AbFero Pharmaceuticals is a company based in Boston (United States) founded in 2016 by Raymond J Bergeron.. AbFero Pharmaceuticals has raised $1.78 million across 5 funding rounds from investors including Eureka Network and Cure Parkinson's. AbFero Pharmaceuticals offers products and services including SP-420. AbFero Pharmaceuticals operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter Boston, United States
- Founders Raymond J Bergeron
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abfero Pharmaceuticals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.78 M (USD)
in 5 rounds
-
Latest Funding Round
$500 K (USD), Seed
Mar 22, 2021
-
Investors
Eureka Network
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AbFero Pharmaceuticals
AbFero Pharmaceuticals offers a comprehensive portfolio of products and services, including SP-420. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Lead candidate for treating iron overload and related conditions.
Funding Insights of AbFero Pharmaceuticals
AbFero Pharmaceuticals has successfully raised a total of $1.78M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $500,000
-
First Round
First Round
(11 Apr 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Seed - AbFero Pharmaceuticals | Valuation |
investors |
|
| Feb, 2021 | Amount | Grant - AbFero Pharmaceuticals | Valuation |
investors |
|
| Dec, 2020 | Amount | Seed - AbFero Pharmaceuticals | Valuation | Eureka |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AbFero Pharmaceuticals
AbFero Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Eureka Network and Cure Parkinson's. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Business management consulting services are offered to clients.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AbFero Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AbFero Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abfero Pharmaceuticals Comparisons
Competitors of AbFero Pharmaceuticals
AbFero Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abfero Pharmaceuticals
Frequently Asked Questions about AbFero Pharmaceuticals
When was AbFero Pharmaceuticals founded?
AbFero Pharmaceuticals was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is AbFero Pharmaceuticals located?
AbFero Pharmaceuticals is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is AbFero Pharmaceuticals a funded company?
AbFero Pharmaceuticals is a funded company, having raised a total of $1.78M across 5 funding rounds to date.
What does AbFero Pharmaceuticals do?
AbFero Pharmaceuticals was founded in 2016 and is based in Boston, United States. Oral iron chelators are developed by the company within the biotechnology sector for addressing iron overload diseases. The lead candidate, SP-420, is designed as an oral treatment for genetic conditions leading to retinal and neurologic disorders, as well as other debilitating effects. Additional solutions are provided for age-related macular degeneration, Parkinsons disease, and traumatic brain injury.
Who are the top competitors of AbFero Pharmaceuticals?
AbFero Pharmaceuticals's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does AbFero Pharmaceuticals offer?
AbFero Pharmaceuticals offers SP-420.
Who are AbFero Pharmaceuticals's investors?
AbFero Pharmaceuticals has 2 investors. Key investors include Eureka Network, and Cure Parkinson's.